Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-05-21

Clinical Trial Update: Effect of Diuretics on Fluid Status Control and Residual Renal Function in Peritoneal Dialysis Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial examining diuretic therapy to manage fluid status and preserve residual renal function in peritoneal dialysis patients was withdrawn, with no re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diuretics

Snippet

Sponsor: Sun Yat-sen University | Conditions: Renal Function Disorder | Phase 3 | Status: WITHDRAWN